CollPlant Holdings

General Information
Business:

(Note: Our ordinary shares currently trade on the Tel Aviv Stock Exchange, or TASE, under the symbol “CLPT,” and the ADSs are currently quoted on the OTCQX marketplace, or OTCQX, under the symbol “CQPTY.”)

We are a clinical-stage regenerative medicine company focused on developing and commercializing tissue repair products, initially for the orthobiologics and advanced wound care markets. Our product candidates are based on our rhCollagen, a form of human collagen produced with our proprietary plant-based genetic engineering technology. We believe our technology is the only commercially viable technology available for the production of genetically engineered, or recombinant, human collagen.

Industry: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Employees: 37
Founded: 1981
Contact Information
Address 3 Sapir Street, Weizmann Science Park, Ness-Ziona 74140, Israel
Phone Number +972 73 232 5600
Web Address https://www.collplant.com
View Prospectus: CollPlant Holdings
Financial Information
Market Cap $35.2mil
Revenues $0 mil (last 12 months)
Net Income $-6.6 mil (last 12 months)
IPO Profile
Symbol CLGN
Exchange NASDAQ
Shares (millions): 3.5
Price range $6.23 - $6.23
Est. $ Volume $25.0 mil
Manager / Joint Managers Ladenburg Thalmann
CO-Managers Roth Capital Partners
Expected To Trade: 12/9/2016
Day: Friday
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change